Hormesis: Calabrese responds

Environmental Health Perspectives

Volumn 118, Issue 4, 2010, Pages 153-154

  Calabrese, Edward J ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; N (2 FLUORENYL)ACETAMIDE;

ALZHEIMER DISEASE; ANALYTIC METHOD; BLADDER CANCER; CALCULATION; CARCINOGENICITY; DOSE RESPONSE; ENVIRONMENTAL HEALTH; FOOD AND DRUG ADMINISTRATION; HORMESIS; LETTER; MEMORY; PRIORITY JOURNAL; PUBLICATION; SCORING SYSTEM;

EID: 77951696101     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0901681r     Document Type: Letter

References (18)

1. Calabrese EJ. 2008a. An assessment of anxiolytic drug screening tests: hormetic dose responses predominate. Crit Rev Toxicol 38:489-542.
2. Calabrese EJ. 2008b. Modulation of the epileptic seizure threshold: implications of biphasic dose responses. Crit Rev Toxicol 38:543-556.
3. Calabrese EJ. 2008c. Alzheimer's disease drugs: an application of the hormetic dose-response model. Crit Rev Toxicol 38:419-452.
4. Calabrese EJ. 2009. Hormesis: a conversation with a critic. Environ Health Perspect 117:1339-1343.
5. Calabrese EJ, Baldwin LA. 2001. The frequency of U-shaped dose response in the toxicological literature. Toxicol Sci 62:330-338.
6. Calabrese EJ, Baldwin LA. 2003. The hormetic dose-response model is more common than the threshold model in toxicology. Toxicol Sci 71:246-250.
7. Calabrese EJ, Stanek EJ, Nascarella M, Hoffmann G. 2008. Hormesis predicts low-dose responses better than threshold models. Inter J Toxicol 27:369-378.
8. Calabrese EJ, Staudenmayer JW, Stanek EJ III, Hoffmann G. 2006. Hormesis outperforms threshold model in National Cancer Institute antitumor drug screening database. Toxicol Sci 94:368-378.
9. Calabrese EJ, Staudenmayer JW, Stanek EJ III, Hoffmann GR. 2007. Hormesis and high throughput studies: Crump's analysis lacks credibility [Letter]. Toxicol Sci 98:602-603.
10. Congdon EE, Figueroa YH, Wang L, Toneva G, Chang E, Kuret J, et al. 2009. Inhibition of tau polymerization with a cyanine dye in two distinct model systems. J Biol Chem 284:20830-20839.
11. Crump KS. 2007. Limitations in the National Cancer Institute antitumor drug screening database for evaluating hormesis [Letter]. Toxicol Sci 98:599-601.
12. Kastin AJ, Pan W. 2008. Peptides and hormesis. Crit Rev Toxicol 38:629-631.
13. Mattson MP. 2008. Awareness of hormesis will enhance future research in basic and applied neuroscience. Crit Rev Toxicol 38:633-639.
14. Mushak P. 2009. Ad hoc and fast forward: the science of hormesis growth and development. Environ Health Perspect 117:1333-1338.
15. Society of Toxicology ED01 Task Force. 1981. Re-examination of the ED01 study. Overview. Fundam Appl Toxicol 1:28-63.
16. Sonneborn JS. 2008. Hormetic triggers for intervention in aging, disease and trauma. Amer J Pharmacol Toxicol 3:4-13.
17. Thong HY, Maibach HI. 2008. Hormesis [biological effects of low level exposure (BELLE)] and dermatology. Dose Response 6:1-15.
18. Zoladz PR, Diamond DM. 2009. Linear and non-linear dose-response functions reveal a hormetic relationship between stress and learning. Dose Response 7:132-148.